232 related articles for article (PubMed ID: 22431984)
1. Epithelial proinflammatory response and curcumin-mediated protection from staphylococcal toxic shock syndrome toxin-1.
Schaefers MM; Breshears LM; Anderson MJ; Lin YC; Grill AE; Panyam J; Southern PJ; Schlievert PM; Peterson ML
PLoS One; 2012; 7(3):e32813. PubMed ID: 22431984
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcal Superantigens Stimulate Epithelial Cells through CD40 To Produce Chemokines.
Schlievert PM; Cahill MP; Hostager BS; Brosnahan AJ; Klingelhutz AJ; Gourronc FA; Bishop GA; Leung DYM
mBio; 2019 Mar; 10(2):. PubMed ID: 30890614
[TBL] [Abstract][Full Text] [Related]
3. The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1.
Peterson ML; Ault K; Kremer MJ; Klingelhutz AJ; Davis CC; Squier CA; Schlievert PM
Infect Immun; 2005 Apr; 73(4):2164-74. PubMed ID: 15784559
[TBL] [Abstract][Full Text] [Related]
4. Use of porcine vaginal tissue ex-vivo to model environmental effects on vaginal mucosa to toxic shock syndrome toxin-1.
Davis CC; Baccam M; Mantz MJ; Osborn TW; Hill DR; Squier CA
Toxicol Appl Pharmacol; 2014 Jan; 274(2):240-8. PubMed ID: 24333258
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Toxic Shock Syndrome-Associated
Schlievert PM; Gaitán AV; Kilgore SH; Roe AL; Maukonen J; Lehtoranta L; Leung DYM; Marsman DS
Microbiol Spectr; 2023 Aug; 11(4):e0173523. PubMed ID: 37404182
[TBL] [Abstract][Full Text] [Related]
6. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
[TBL] [Abstract][Full Text] [Related]
7. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
[TBL] [Abstract][Full Text] [Related]
8. Contribution of toxic shock syndrome toxin-1 to systemic inflammation investigated by a mouse model of cervicovaginal infection with Staphylococcus aureus.
Asano K; Narita K; Hirose S; Nakane A
Med Microbiol Immunol; 2018 Nov; 207(5-6):297-306. PubMed ID: 29980843
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.
Bonventre PF; Heeg H; Cullen C; Lian CJ
Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600
[TBL] [Abstract][Full Text] [Related]
10. Vaginal community state types (CSTs) alter environmental cues and production of the
Maduta CS; McCormick JK; Dufresne K
J Bacteriol; 2024 Mar; 206(3):e0044723. PubMed ID: 38334326
[TBL] [Abstract][Full Text] [Related]
11. A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1).
Breshears LM; Schlievert PM; Peterson ML
J Biol Chem; 2012 Sep; 287(39):32578-87. PubMed ID: 22833676
[TBL] [Abstract][Full Text] [Related]
12. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
[TBL] [Abstract][Full Text] [Related]
13. Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds.
Kimber I; Nookala S; Davis CC; Gerberick GF; Tucker H; Foertsch LM; Dearman RJ; Parsonnet J; Goering RV; Modern P; Donnellen M; Morel J; Kotb M
Toxicol Sci; 2013 Jul; 134(1):49-63. PubMed ID: 23640863
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
De Boer ML; Kum WW; Chow AW
Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
[TBL] [Abstract][Full Text] [Related]
15. Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins.
Lee PK; Deringer JR; Kreiswirth BN; Novick RP; Schlievert PM
Infect Immun; 1991 Mar; 59(3):879-84. PubMed ID: 1997438
[TBL] [Abstract][Full Text] [Related]
16. Toxic shock syndrome toxin-1-mediated toxicity inhibited by neutralizing antibodies late in the course of continual in vivo and in vitro exposure.
Stich N; Model N; Samstag A; Gruener CS; Wolf HM; Eibl MM
Toxins (Basel); 2014 May; 6(6):1724-41. PubMed ID: 24887085
[TBL] [Abstract][Full Text] [Related]
17. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
Bonventre PF; Weckbach L; Harth G; Haidaris C
Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
[TBL] [Abstract][Full Text] [Related]
18. Epidermal Growth Factor Receptor Signaling Enhances the Proinflammatory Effects of Staphylococcus aureus Gamma-Toxin on the Mucosa.
Gillman AN; Breshears LM; Kistler CK; Finnegan PM; Torres VJ; Schlievert PM; Peterson ML
Toxins (Basel); 2017 Jun; 9(7):. PubMed ID: 28657583
[No Abstract] [Full Text] [Related]
19. The Superantigen Toxic Shock Syndrome Toxin 1 Alters Human Aortic Endothelial Cell Function.
Kulhankova K; Kinney KJ; Stach JM; Gourronc FA; Grumbach IM; Klingelhutz AJ; Salgado-Pabón W
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29229737
[No Abstract] [Full Text] [Related]
20. Novel toxic shock syndrome toxin-1 amino acids required for biological activity.
Brosnahan AJ; Schaefers MM; Amundson WH; Mantz MJ; Squier CA; Peterson ML; Schlievert PM
Biochemistry; 2008 Dec; 47(49):12995-3003. PubMed ID: 19012411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
